Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Usefulness of colestimide for diarrhea in postoperative Crohn's disease.
Hojo A, Kobayashi T, Matsubayashi M, Morikubo H, Miyatani Y, Fukuda T, Asonuma K, Sagami S, Nakano M, Matsuda T, Hibi T. Hojo A, et al. Among authors: matsubayashi m. JGH Open. 2022 Jul 14;6(8):547-553. doi: 10.1002/jgh3.12786. eCollection 2022 Aug. JGH Open. 2022. PMID: 35928696 Free PMC article.
Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S-methyltransferase inhibition.
Morikubo H, Kobayashi T, Ozaki R, Okabayashi S, Kuronuma S, Takeuchi O, Shiba T, Kiyohara H, Matsubayashi M, Sagami S, Nakano M, Ikezaki O, Hisamatsu T, Tanaka Y, Hibi T. Morikubo H, et al. Among authors: matsubayashi m. J Gastroenterol Hepatol. 2021 Aug;36(8):2116-2124. doi: 10.1111/jgh.15411. Epub 2021 Jan 29. J Gastroenterol Hepatol. 2021. PMID: 33470487
Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitis.
Sagami S, Kobayashi T, Aihara K, Umeda M, Odajima K, Morikubo H, Asonuma K, Miyatani Y, Fukuda T, Matsubayashi M, Kiyohara H, Nakano M, Hibi T. Sagami S, et al. Among authors: matsubayashi m. Aliment Pharmacol Ther. 2022 May;55(10):1320-1329. doi: 10.1111/apt.16817. Epub 2022 Feb 25. Aliment Pharmacol Ther. 2022. PMID: 35218038
Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study.
Asonuma K, Ozeki K, Yamazaki H, Okabayashi S, Okano S, Ozaki R, Nishimata N, Kiyohara H, Ichinari N, Kobayashi T, Yamada M, Matsubayashi M, Yokoyama Y, Arimitsu S, Umeno J, Munetomo Y, Andoh A, Shinzaki S; IBD Terakoya Group. Asonuma K, et al. Among authors: matsubayashi m. J Gastroenterol Hepatol. 2024 Jan;39(1):66-73. doi: 10.1111/jgh.16376. Epub 2023 Oct 12. J Gastroenterol Hepatol. 2024. PMID: 37823425
Health-related quality of life in health states corresponding to different stages of perianal fistula associated with Crohn's disease: a quantitative evaluation of patients and non-patients in Japan.
Kato M, Yoneyama-Hirozane M, Iwasaki K, Matsubayashi M, Igarashi A. Kato M, et al. Among authors: matsubayashi m. J Mark Access Health Policy. 2023 Jan 15;11(1):2166374. doi: 10.1080/20016689.2023.2166374. eCollection 2023. J Mark Access Health Policy. 2023. PMID: 36684854 Free PMC article.
NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice.
Maeda S, Hikiba Y, Fujiwara H, Ikenoue T, Sue S, Sugimori M, Matsubayashi M, Kaneko H, Irie K, Sasaki T, Chuma M. Maeda S, et al. Among authors: matsubayashi m. Cancer Sci. 2021 Apr;112(4):1471-1480. doi: 10.1111/cas.14828. Epub 2021 Feb 14. Cancer Sci. 2021. PMID: 33506599 Free PMC article.
152 results